Efficacy of a Modified Banxia Xiexin Decoction for the "Wei-Pi" Syndrome (Postprandial Distress Syndrome)

Postprandial Distress Syndrome Clinical Trial

Official title: Efficacy of a Modified Banxia Xiexin Decoction (BXD) for the "Wei-Pi" Syndrome (Postprandial Distress Syndrome): a Randomized, Waitlist Controlled Trial

Status Completed

Clinical Trial Summary

The study aims to evaluate the efficacy of a modified Banxia Xiexin Decoction (BXD) for Wei-Pi through a randomized, waitlist controlled trial.

Clinical Trial Description

After being informed about the study plan, potential risk and benefits, all subjects will give written informed consent prior to participation and undergo eligibility screening. Eligible participants will be randomized, in a 1:1 ratio, into BXD group and waitlist group. ;

Related Conditions & MeSH terms

• Postprandial Distress Syndrome
• Syndrome

• NCT number: NCT04398888
• Study type: Interventional
• Source: The University of Hong Kong
• Status: Completed
• Phase: N/A
• Start date: August 1, 2020
• Completion date: September 30, 2021